Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Preparation and Use of Calibration Standards – V 2.0

Posted on By

BA-BE Studies: SOP for Preparation and Use of Calibration Standards – V 2.0

Standard Operating Procedure for Preparation and Use of Calibration Standards in Bioanalytical Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/153/2025
Supersedes SOP/BA-BE/153/2022
Page No. Page 1 of 11
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To outline the procedure for preparation, handling, storage, and application of calibration standards used in the quantification of analytes in bioanalytical studies, ensuring accuracy and compliance with regulatory guidelines.

2. Scope

This SOP applies to all calibration standards prepared and used in quantitative bioanalytical methods performed in the laboratory for BA/BE studies involving human plasma or other biological matrices.

3. Responsibilities

  • Bioanalytical Analyst: Prepares calibration standards, maintains records, and verifies concentrations.
  • Reviewer (Team Lead/QA): Verifies calculations, labels, and storage records of prepared calibration standards.
  • Lab Supervisor: Ensures availability of qualified personnel and proper equipment for preparation.
See also  BA-BE Studies: SOP for Audio-Visual Consent Recording in India - V 2.0

4. Accountability

The Head of the Bioanalytical Laboratory is accountable for the accuracy and traceability of all calibration standards used in analytical runs.

5. Procedure

5.1 Preparation of Stock Solution

  1. Weigh the required amount of certified reference standard using an analytical balance (calibrated as per SOP).
  2. Dissolve in an appropriate solvent (e.g., methanol, acetonitrile, or buffer) to achieve the desired concentration (e.g., 1 mg/mL).
  3. Record all weights, solvents used, lot numbers, and calculation steps in Annexure-1: Calibration Stock Preparation Log.

5.2 Preparation of Working Solution

  1. Prepare a working solution from the stock by appropriate dilution using suitable diluent.
  2. Ensure accuracy by using calibrated pipettes and volumetric glassware.
  3. Calculate final concentrations and verify independently by a second analyst.
  4. Document details in Annexure-2: Working Standard Preparation Record.

5.3 Spiking of Calibration Standards

  1. Aliquot blank matrix (plasma, serum, etc.) into labeled microcentrifuge or polypropylene tubes.
  2. Spike appropriate volumes of working solution into each tube to prepare calibration levels.
  3. Typical levels: LLOQ, Low QC, Mid QC, High QC, and ULOQ (e.g., 7 to 9 levels).
  4. Mix samples thoroughly by vortexing; record spiking volumes and calculations in Annexure-3.
See also  BA-BE Studies: SOP for Preventive Maintenance of Analytical Instruments - V 2.0

5.4 Labeling and Storage

  1. Label each spiked tube clearly with:
    • Analyte name
    • Concentration
    • Date of preparation
    • Expiry date
  2. Store calibration standards at temperatures validated for analyte stability (e.g., -20°C).
  3. Track usage and expiration using Annexure-4: Calibration Standard Inventory Log.

5.5 Usage in Analytical Runs

  1. Thaw calibration standards at room temperature and vortex before use.
  2. Run calibration standards in each batch in duplicate to generate a calibration curve.
  3. Acceptance Criteria:
    • ≥75% of non-zero calibrators within ±15% (±20% at LLOQ)
    • Correlation coefficient (r²) ≥0.99

5.6 Documentation and Archival

  1. Ensure all preparation, usage, and storage records are completed in ink and verified.
  2. Scan and store documentation electronically as per lab data archival policy.

6. Abbreviations

  • BA/BE: Bioavailability/Bioequivalence
  • LLOQ: Lower Limit of Quantification
  • ULOQ: Upper Limit of Quantification
  • QC: Quality Control
  • r²: Correlation Coefficient

7. Documents

  1. Calibration Stock Preparation Log – Annexure-1
  2. Working Standard Preparation Record – Annexure-2
  3. Spiking Calculation Sheet – Annexure-3
  4. Calibration Standard Inventory Log – Annexure-4
See also  BA-BE Studies: SOP for Trial Registration with EudraCT - V 2.0

8. References

  • ICH M10: Bioanalytical Method Validation
  • US FDA Guidance for Industry – Bioanalytical Method Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Calibration Stock Preparation Log

Date Compound Weight (mg) Solvent Final Volume Prepared By
15/04/2025 XYZ-101 10.0 MeOH 10 mL Rajesh Kumar

Annexure-2: Working Standard Preparation Record

Stock ID Dilution Factor Concentration Volume Prepared By
STK-XYZ101 1:10 100 μg/mL 5 mL Sunita Reddy

Annexure-3: Spiking Calculation Sheet

Level Target Conc. (ng/mL) Plasma Volume Spike Volume Total Volume
LQC 50 450 μL 50 μL 500 μL

Annexure-4: Calibration Standard Inventory Log

Standard ID Level Prep Date Expiry Storage Temp Status
CAL-XYZ-LQC LQC 15/04/2025 30/04/2025 -20°C In Use

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
17/04/2025 2.0 Expanded preparation steps and added inventory tracking Regulatory Update QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0
Next Post: Gel Manufacturing: SOP for Bulk Storage of Gels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version